Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Korean Journal of Clinical Pharmacy
>
2021
>
31
>
2
Volume:
31
Issue:
2
1. Apixaban versus Warfarin in Patients with Chronic Kidney Disease; A Systematic Review and Meta-analysis
Page:87—95
2. Awareness on expiration date of repackaged prescription medications and pulverization of solid pills: A questionnaire study
Page:96—103
3. Exploring the Perception on Drug Utilization Review System and DUR Modernization Pilot Project: A Qualitative Study Using Focus Group Interviews
Page:104—114
4. Pain-related Prescribing Patterns and Associated Factor in Breast Cancer Patients
Page:115—124
5. Compatibility Study between Physiologically Based Pharmacokinetic (PBPK) and Compartmental PK Model Using Lumping Method: Application to the Voriconazole Case
Page:125—135
6. Clinical Effects of Zinc Supplementation in Patients Hospitalized with COVID-19:A Systematic Review and Meta-analysis
Page:136—144
7. A Survey on Willingness to Accept Community Pharmacist’s Consultation Service Regarding Well-dying
Page:145—152
8. Analysis of Medical Use and Treatment Costs of Hepatocellular Carcinoma Patients Using National Patient Sample Data
Page:153—159
9. Apixaban versus Warfarin in Patients with Chronic Kidney Disease; A Systematic Review and Meta-analysis
Page:87—95
10. Awareness on expiration date of repackaged prescription medications and pulverization of solid pills: A questionnaire study
Page:96—103
11. Exploring the Perception on Drug Utilization Review System and DUR Modernization Pilot Project: A Qualitative Study Using Focus Group Interviews
Page:104—114
12. Pain-related Prescribing Patterns and Associated Factor in Breast Cancer Patients
Page:115—124
13. Compatibility Study between Physiologically Based Pharmacokinetic (PBPK) and Compartmental PK Model Using Lumping Method: Application to the Voriconazole Case
Page:125—135
14. Clinical Effects of Zinc Supplementation in Patients Hospitalized with COVID-19:A Systematic Review and Meta-analysis
Page:136—144
15. A Survey on Willingness to Accept Community Pharmacist’s Consultation Service Regarding Well-dying
Page:145—152
16. Analysis of Medical Use and Treatment Costs of Hepatocellular Carcinoma Patients Using National Patient Sample Data
Page:153—159